These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 3720792)

  • 21. Pharmacokinetics of the gastrokinetic agent mosapride citrate after single and multiple oral administrations in healthy subjects.
    Sakashita M; Yamaguchi T; Miyazaki H; Sekine Y; Nomiyama T; Tanaka S; Miwa T; Harasawa S
    Arzneimittelforschung; 1993 Aug; 43(8):867-72. PubMed ID: 8216445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase Ib single- and multiple-dose pharmacokinetic study of oral NV-52 in healthy volunteers.
    Howes LG; Howes JB; Huang JL; Walker C
    Drugs R D; 2008; 9(3):159-66. PubMed ID: 18457468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple-dose pharmacokinetics of ofloxacin, a new broad-spectrum antimicrobial agent.
    Dagrosa EE; Verho M; Malerczyk V; de Looze S; Hajdú P; Toyodera K
    Clin Ther; 1986; 8(6):632-45. PubMed ID: 3466701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I trial of temozolomide (NSC 362856) in patients with advanced cancer.
    Dhodapkar M; Rubin J; Reid JM; Burch PA; Pitot HC; Buckner JC; Ames MM; Suman VJ
    Clin Cancer Res; 1997 Jul; 3(7):1093-100. PubMed ID: 9815788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration.
    Meyer MC; Straughn AB; Lo MW; Schary WL; Whitney CC
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):15-9. PubMed ID: 6469932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism, kinetics and metabolic activity of the beta-cytotropic antidiabetic 4-(5-isobutylpyrimidinyl-2)-sulphamylphenylacetic acid-3-chloro-6-methoxyanilide sodium (glydanile sodium) in man after oral and intravenous administration.
    Gerhards E; Berger D; Peters S
    Arzneimittelforschung; 1976 Feb; 26(2):278-86. PubMed ID: 947213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of lorcainide in man: a new antiarrhythmic agent.
    Klotz U; Müller-Seydlitz P; Heimburg P
    Clin Pharmacokinet; 1978; 3(5):407-18. PubMed ID: 699462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile.
    Heggie GD; Sommadossi JP; Cross DS; Huster WJ; Diasio RB
    Cancer Res; 1987 Apr; 47(8):2203-6. PubMed ID: 3829006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single dose pharmacokinetics of fendiline in humans.
    Kukovetz WR; Brunner F; Beubler E; Weyhenmeyer R; Lohaus R; Grob M; Mayer D
    Eur J Drug Metab Pharmacokinet; 1982; 7(2):105-10. PubMed ID: 7117293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical pharmacokinetics of mycophenolate mofetil.
    Bullingham RE; Nicholls AJ; Kamm BR
    Clin Pharmacokinet; 1998 Jun; 34(6):429-55. PubMed ID: 9646007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single and multiple dose pharmacokinetics of sultosilic acid in humans.
    Roser R; Martinez L; Pares S; Sagarra R; Esteve J
    Eur J Drug Metab Pharmacokinet; 1986; 11(1):1-7. PubMed ID: 3720792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The metabolism of the hypolipidaemic drug sultosilic acid in rat, dog and man.
    Wood SG; Kirkpatrick D; Jackson AJ; Hawkins DR; Down WH; Chasseaud LF; Biggs SR; Darragh A
    Xenobiotica; 1982 Mar; 12(3):165-76. PubMed ID: 7113253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of ebrotidine in healthy volunteers. A summary.
    Albet C; Pérez JA; Rozman E; Márquez M; Herrero E; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):535-9. PubMed ID: 9205760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic study of ebrotidine administered in multiple doses to healthy volunteers for 4 days.
    Frías J; Esteban C; Carcas AJ; Sánchez-García P; Albet C; Torres J; Márquez M; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):531-4. PubMed ID: 9205759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of rufloxacin in healthy volunteers after repeated oral doses.
    Mattina R; Bonfiglio G; Cocuzza CE; Gulisano G; Cesana M; Imbimbo BP
    Chemotherapy; 1991; 37(6):389-97. PubMed ID: 1662127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical effectiveness of piperazine sultosylate in the hyperlipidemias].
    Casellas Bernat A; Ribas Grau M; Casellas Bernat G; Riera de Barcia L; Alou Llado M; Solivellas Antich S
    Rev Clin Esp; 1981 Apr; 161(1):5-8. PubMed ID: 7255818
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.